RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Total debt

ABBOTT LABORATORIESABT

Market cap
$221.4B
P/E ratio
SummaryFinancials
Period EndTotal debt (Million USD)YoY (%)
Dec 31, 202414,125-3.77%
Dec 31, 202314,679-12.48%
Dec 31, 202216,773-7.07%
Dec 31, 202118,050-2.61%
Dec 31, 202018,534+3.32%
Dec 31, 201917,938-7.37%
Dec 31, 201819,366-30.13%
Dec 31, 201727,718+34.01%
Dec 31, 201620,684+252.13%
Dec 31, 20155,874+70.36%
Dec 31, 20143,448+1.50%
Dec 31, 20133,397-81.53%
Dec 31, 201218,394+40.77%
Dec 31, 201113,067-10.31%
Dec 31, 201014,568

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)